News & Publications Lessons Learned from a COVID-19 Treatment Trial July 25, 2022, 07:45 AM by Corri Levine, PhD An analysis of the NETEC Special Pathogens Research Network’s participation in the Adaptive COVID-19 Treatment Trial (ACTT) early in the pandemic identifies nine lessons for participating in clinical trials during an emergency Ghana declares first-ever outbreak of Marburg virus disease July 20, 2022, 15:34 PM by World Health Organization Accra/Brazzaville - Ghana has announced the country’s first outbreak of Marburg virus disease, after a World Health Organization (WHO) Collaborating Centre laboratory confirmed earlier results. Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment Trial July 7, 2022, 10:48 AM by User Not Found Corri B. Levine, et al. - Health Security, May 31, 2022 Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response July 7, 2022, 10:47 AM by User Not Found Jonathan D. Grein, et al. - Health Security, May 31, 2022 Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial July 7, 2022, 10:45 AM by User Not Found Cameron R. Wolfe, et al. - The Lancet Respiratory Medicine, May 23, 2022 Unravelling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2 July 7, 2022, 10:44 AM by User Not Found Jonathan Fintzi, et al. - Open Forum Infectious Diseases, April 27, 2022 Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial July 7, 2022, 10:41 AM by User Not Found Andre C. Kalil, et al. - The Lancet Respiratory Medicine, October 18, 2021 Synthetic proteins for COVID-19 diagnostics July 7, 2022, 10:39 AM by User Not Found Catherine H. Schein, et al. - Peptides, September, 2021 Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization July 7, 2022, 10:38 AM by Jonathan Fintzi, et al. Clinical Infectious Disease, August 19, 2021 Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19 July 7, 2022, 10:25 AM by User Not Found Andre C. Kalil, et al. - New England Journal of Medicine, March 4, 2021 Remdesivir for the Treatment of COVID-19 – Final Report July 7, 2022, 10:24 AM by User Not Found John H. Beigel, et al. - New England Journal of Medicine, November 5, 2020 Multicycle Autoclave Decontamination of N95 Filtering Facepiece Respirators July 7, 2022, 10:22 AM by User Not Found Nathen E. Bopp, et al. - Applied Biosafety, September 1, 2020 UTMB’s new Biocontainment Care Unit is prepared for the next Ebola Outbreak July 7, 2022, 10:14 AM by Shanley Pierce Shanley Pierce - TMC News, May 10, 2019 1 2 3 4 5 6 7 8
Lessons Learned from a COVID-19 Treatment Trial July 25, 2022, 07:45 AM by Corri Levine, PhD An analysis of the NETEC Special Pathogens Research Network’s participation in the Adaptive COVID-19 Treatment Trial (ACTT) early in the pandemic identifies nine lessons for participating in clinical trials during an emergency
Ghana declares first-ever outbreak of Marburg virus disease July 20, 2022, 15:34 PM by World Health Organization Accra/Brazzaville - Ghana has announced the country’s first outbreak of Marburg virus disease, after a World Health Organization (WHO) Collaborating Centre laboratory confirmed earlier results.
Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment Trial July 7, 2022, 10:48 AM by User Not Found Corri B. Levine, et al. - Health Security, May 31, 2022
Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response July 7, 2022, 10:47 AM by User Not Found Jonathan D. Grein, et al. - Health Security, May 31, 2022
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial July 7, 2022, 10:45 AM by User Not Found Cameron R. Wolfe, et al. - The Lancet Respiratory Medicine, May 23, 2022
Unravelling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2 July 7, 2022, 10:44 AM by User Not Found Jonathan Fintzi, et al. - Open Forum Infectious Diseases, April 27, 2022
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial July 7, 2022, 10:41 AM by User Not Found Andre C. Kalil, et al. - The Lancet Respiratory Medicine, October 18, 2021
Synthetic proteins for COVID-19 diagnostics July 7, 2022, 10:39 AM by User Not Found Catherine H. Schein, et al. - Peptides, September, 2021
Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization July 7, 2022, 10:38 AM by Jonathan Fintzi, et al. Clinical Infectious Disease, August 19, 2021
Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19 July 7, 2022, 10:25 AM by User Not Found Andre C. Kalil, et al. - New England Journal of Medicine, March 4, 2021
Remdesivir for the Treatment of COVID-19 – Final Report July 7, 2022, 10:24 AM by User Not Found John H. Beigel, et al. - New England Journal of Medicine, November 5, 2020
Multicycle Autoclave Decontamination of N95 Filtering Facepiece Respirators July 7, 2022, 10:22 AM by User Not Found Nathen E. Bopp, et al. - Applied Biosafety, September 1, 2020
UTMB’s new Biocontainment Care Unit is prepared for the next Ebola Outbreak July 7, 2022, 10:14 AM by Shanley Pierce Shanley Pierce - TMC News, May 10, 2019